As of Jul 22
| -0.14 / -0.13%|
The 5 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 115.00, with a high estimate of 118.00 and a low estimate of 102.00. The median estimate represents a +3.84% increase from the last price of 110.75.
The current consensus among 6 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.